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Abstract
Inhibitor of DNA binding 2 (ID2) is a helix-loop-helix transcriptional repressor rhythmically 
expressed in many adult tissues. Our previous studies have demonstrated that Id2 null mice have 
altered expression of circadian genes involved in lipid metabolism, altered circadian feeding 
behavior, and sex-specific enhancement of insulin sensitivity and elevated glucose uptake in 
skeletal muscle and brown adipose tissue. Here we further characterized the Id2−/− mouse 
metabolic phenotype in a sex-specific context and under low and high fat diets, and examined 
metabolic and endocrine parameters associated with lipid and glucose metabolism. Under the low-
fat diet Id2−/− mice showed decreased weight gain, reduced gonadal fat mass, and a lower 
survival rate. Under the high-fat diet, body weight and gonadal fat gain of Id2−/− male mice was 
comparable to control mice and survival rate improved markedly. Furthermore, the high-fat diet 
treated Id2−/− male mice lost the enhanced glucose tolerance feature observed in the other Id2−/− 
groups, and there was a sex-specific difference in white adipose tissue storage of Id2−/− mice. 
Additionally, a distinct pattern of hepatic lipid accumulation was observed in Id2−/− males: low 
lipids on the low-fat diet and steatosis on the high-fat diet. In summary, these data provides 
valuable insights into the impact of Id2 deficiency on metabolic homeostasis of mice in a sex-
specific manner.
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Introduction
Inhibitor of DNA binding, (Id) genes, encode helix-loop-helix (HLH) transcription factors 
lacking a DNA binding domain, that act as dominant negative regulators of basic HLH 
transcription factors [1,2]. The Id gene family includes four genes (Id1-4), which are 
involved in the regulation of many biological processes, including the cell cycle, circadian 
rhythms and adipocyte differentiation [1,2,3,4]. Recent studies have revealed a role for Id1 
in the regulation of insulin secretion and β-cell differentiation [5], and Id4 in adipocyte 
differentiation and adipose tissue formation [6].
ID2 is rhythmically expressed in many mammalian tissues and is involved in the input 
pathway, core clock function and output pathways of the circadian clock [3,7,8]. ID2 
contributes to the output pathways of the circadian clock as demonstrated in Id2−/− mice by 
the expression profiles of clock controlled genes in the liver, including those involved in 
lipid metabolism [3]. Moreover, studies have shown that absence of Id2 results in impaired 
adipogenesis in vitro and that Id2−/− mice have reduced gonadal white adipose tissue 
(WAT) and lipid content in the liver [3,4]. Our previous findings demonstrated that Id2−/− 
mice exhibit altered feeding and locomotor rhythms, sex- and age-dependent enhanced 
glucose tolerance and insulin sensitivity, and sex-dependent elevated glucose uptake in 
skeletal muscle and brown adipose tissue [9]. It is well known that risk, development and 
manifestation of obesity, metabolic syndrome and insulin-resistance are sexually dimorphic 
[10,11]. Here we extend our studies on the characterization of the Id2−/− mouse metabolic 
phenotype under energy-rich diet challenge in a sex-specific context.
Materials and Methods
Animals
The generation and husbandry of Id2−/− mice, and determination of genotypes, was 
performed as described previously [7,9]. Id2+/+ wild-type (WT) and Id2−/− mice were on a 
mixed background for breeding purposes: 129sv/C57BL6J/FBVN [7,9]. Mice were 
maintained on a regular chow diet (Kal – 22:23:55 by % calculation as fat: protein: 
carbohydrate; Teklad Global diet 2919) provided ad libitum, and with sterile water 
containing antibiotic [3,7,9]. All mice were housed in laboratory cages at temperature of 
20°–21°C and humidity of 50–65% under a 12:12 light: dark (LD) cycle with lights on at 
Zeitgeber time (ZT) 0 and lights off at ZT12. Starting at age wk 8–10, mice were fed ad 
libitum with either a low fat diet (LFD; Kal – 12:22:66; Harlan Laboratories: 2916) or a high 
fat diet (HFD; Kal – 45:20:35, Research Diet Inc: D12451). Littermate mice were used as 
control animals, assignment to diet groups was randomized, and apart from the change in 
diet all other conditions were as detailed above. All animal experiments were approved by 
the University of Notre Dame Animal Care and Use Committee and performed in 
accordance with NIH Guidelines for the Care and Use of Laboratory Animals.
For the growth curves, 48 WT and 39 Id2−/− mice were weighed weekly for 17 wk. For the 
survival rate, the percentage of surviving animals over a period of 20 wk was determined. 
The in vivo body fat composition of WT and Id2−/− mice was measured ranging from age 
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12 to 19 wk. Mice were aged 32–34 wk at end of experiment when tissues were harvested 
for phenotyping.
Glucose tolerance tests
After 18 wk on LFD or HFD, mice were subjected to glucose tolerance testing. Mice were 
fasted overnight (16 h) and given an intra-peritoneal injection of D-glucose (1.5g/kg of body 
mass) at ZT4. Subsequent blood glucose were measured at 0, 10, 20, 30, 60, 90, and 120 
min from a distal tail vein as previously described [9].
Fat mass estimation
In vivo X-ray Micro-Computed Tomography (MicroCT) was used to quantify percent body 
fat (see Supplementary information for full methods).
Analysis of serum and liver lipid and endocrine panels
At the age of 32–34 wk, and 22 wk of feeding experiment, serum and liver were harvested at 
ZT4 for lipid and endocrine analysis, and conducted at the UC Davis Mouse Metabolic 
Phenotyping Center (MMPC; Davis, CA) (see Supplementary information for full methods).
Tissue mass and histology
At the end of the feeding experiment, gonadal WAT deposits and interscapular brown 
adipose tissue (iBAT) were excised and weighed. Cryostat cut WAT sections were prepared 
and stained with hematoxylin-eosin as described [9]. For lipid analysis, cryostat cut liver 
sections were stained for Oil-red-O and hematoxylin-eosin, as described [12]. Multiple 
images were captured at 20x and 10x magnification for WAT and liver, respectively, using a 
Nikon 90i wide field microscope with a Nikon DS-Fi1 digital camera. To measure WAT cell 
area and liver lipid accumulation, three to five sections from each animal were analyzed 
manually using NIH ImageJ software and using methods previously described [9,12].
Statistics
Data were analyzed using Sigma Plot 12.0 software (Chicago, IL) to run two-factor 
ANOVA, two-factor repeated measures (RM) ANOVA and three-factor ANOVA with 
genotype, sex and diet as the independent variables. Tukey’s post hoc tests were performed 
when significant ANOVA results between factors were revealed. Where necessary, data 
were natural log, square root or ranks transformed to correct for non-normal distributions. 
The survival rate data were analyzed by using χ2 analyses (and Fisher’s exact tests) for trend 
(Prism 5.0, Graphpad, La Jolla, CA).
Results
High fat diet ameliorates Id2−/− male mice phenotype and survival rate
The lean and lower body mass phenotype of Id2−/− mice reported in our previous studies 
raised the question as to whether this animal phenotype is affected by a HFD [3,7,9]. 8–10-
wk-old Id2−/− mice and their WT littermates were put on LFD and HFD for 22 wk. WT 
mice gained weight indistinguishably on both diets, presumably due to their mixed genetic 
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background, which may cause resistance to diet-induced obesity on a HFD [13] (Fig. 1A). 
Conversely, Id2−/− males gained more weight and became heavier on HFD than on a LFD 
by the end of experiment (Time (T), p<0.001; Diet (D), n.s.; Interaction (I), p<0.05) (Fig. 
1A). However, this pattern of weight gain was not observed in Id2−/− females (T, p<0.001; 
D, n.s.; I, n.s.) (Fig. 1A). When the body weights of WT and Id2−/− mice were normalized 
to their initial weight, the growth rate of Id2−/− males was found to be lower than their WT 
counterparts when fed the LFD (T, p<0.001; Genotype (G), n.s.; I, p<0.01) (Fig. 1B). 
However, under HFD, Id2−/− males showed nearly the same growth rate as their WT 
littermates (T, p<0.001; G, n.s.; I, n.s.). Id2−/− females grew significantly less than WTs 
under LFD (T, p<0.001; G, p<0.01; I, p<0.001) and exhibited a lower growth rate than WTs 
under HFD (T, p<0.001; G, n.s.; I, p<0.05) (Fig. 1B). We also monitored the survival rate of 
the WT and Id2−/− mice during the 20 wk experiment. Surprisingly, none of the Id2−/− 
males died on the HFD, whereas the survival rate of Id2−/− males on LFD dropped to under 
65%; and only 56% and 67% of Id2−/− females on LFD and HFD, respectively, reached the 
age of 20 wk, (χ2 test for trend: HFD male, p<0.001, different from other 3 groups) (Fig. 
1C). The remaining three Id2−/− groups were not different from one another (χ2 test for 
trend, n.s.). There was no significant decline in body weight prior to death, as compared 
with susceptible Id2−/− mice groups, measured over 4 weeks prior to death (two factor 
ANOVA, n.s.). Note that all WT mice survived irrespective of sex and diet.
High fat diet modulates Id2−/− male mice glucose homeostasis
Our previous study revealed that male, but not female, Id2−/− mice exhibit an enhanced 
glucose tolerance when fed with a regular chow diet (22% kcal% from fat) [9]. To assess the 
consequences of diet on Id2−/− mouse glucose homeostasis, glucose tolerance tests were 
performed on these mice after 17 wk on LFD or HFD. Id2−/− males had an enhanced 
glucose tolerance under LFD compared to WTs (Time (T), p<0.001; Genotype (G), 
p<0.001; Interaction (I), n.s.) (Fig. 2A). In contrast, no difference in glucose tolerance 
between male Id2−/− and WT mice on HFD was observed (T, p<0.001; G, n.s.; I, n.s.) In 
the female mice, an enhanced glucose tolerance was observed in Id2−/− mice fed with 
either LFD (T, p<0.001; G, p<0.001; I, n.s.) or fed with HFD (T, p<0.001; G, p<0.001; I, 
n.s.) (Fig. 2B).
Modulation of fat storage of Id2−/− male mice under high fat diet
The apparent weight gain of Id2−/− males under HFD raised a question as to whether the 
increased body mass in these animals was associated with an increase in fat mass. Therefore, 
we examined and quantified the amount of fat tissue present in WT and Id2−/− animals fed 
the LFD and HFD. A representative 3D visual display of fat deposits in WT and Id2−/− 
males is shown in Fig. 3A. Analysis by MicroCT revealed no difference in fat/total volume 
ratio between Id2−/− and WT males fed with LFD, whereas Id2−/− males on HFD had a 
significant increase in this ratio compared to WTs (Genotype (G), n.s.; Diet (D), p<0.001, 
Interaction (I), p=0.05) (Fig. 3B). There was no difference in fat/total volume ratio between 
WT and Id2−/− females when fed with LFD. However, Id2−/− females had a significantly 
lower fat/total volume ratio compared to WTs when fed with HFD (G, p<0.01.; D, p<0.05, 
I, p<0.05) (Fig. 3B). The trends observed from global body fat of WT and Id2−/− mice fed 
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with the two diets were consistent with those of the lower abdominal fat (LAF) trends (male: 
G, n.s.; D, p<0.01; I, n.s.; female: G, p<0.01; D, n.s.; I, n.s.) (Fig. 3B). Moreover, at the end 
of the experiment, at wk 22, perigonadal adipose tissue in WT and Id2−/− mice was 
harvested and weighed (Fig. 3C). The weight ratio of fat from gonadal WAT was lower in 
Id2−/− males than that from WT males fed with the LFD. However, these differences were 
not observed in Id2−/− male fed with HFD (G, p<0.05; D, p<0.001; I, n.s.). Id2−/− females 
had a lower gonadal WAT weight ratio in both diets when compared to WT females (G, 
p<0.001; D, p<0.05; I, n.s.). No difference in iBAT weight ratios was observed between 
WT and Id2−/− mice when fed with LFD and HFD (two factor ANOVA: n.s.) (Fig. 3C). 
The actual weight trends of gonadal WAT and iBAT were comparable to those of weight 
ratio trends (Supplemental Fig. 1A,C). Histological evaluation of gonadal WAT revealed no 
significant difference between genotype, although the trends of adipocyte size in the female 
LFD group were comparable to our previous study, but less pronounced (Supplemental Fig. 
1B) [9].
High fat diet modulates lipid metabolic homeostasis of Id2−/− mice
At the end of the 22 wk of controlled diet, and at the age of 32–34 wk, serum and liver were 
collected from mice following overnight fasting. Table 1 shows the lipid and endocrine 
parameters measured for these surviving mice. No difference of serum triglyceride (TG) 
levels was observed between genotypes in either males and females when fed with LFD or 
HFD (Table 1, Supplemental Fig. 2A). However, the serum total cholesterol levels were 
significantly lower in Id2−/− males fed with HFD (Table 1, Fig. 4A). Also, serum LDL 
cholesterol levels were lower in Id2−/− males fed with HFD in comparison with diet and 
sex-matched WTs (Table 1, Fig. 4A). A similar pattern was observed in serum HDL 
cholesterol levels, although this pattern was less pronounced and did not reach statistical 
significance (Table 1, Supplemental Fig. 2A). There was no significant difference in insulin 
levels between genotype, sex and diet (Table 1, Supplemental Fig. 2B). However, Id2−/− 
females were found to have elevated glucagon levels when fed with HFD (Table 1, 
Supplemental Fig. 2B). The serum leptin levels were found to be consistently lower in Id2−/
− mice, irrespective of diet and sexes. However, the reduction between male Id2−/− and 
WT mice fed with HFD was not observed to be significant in post hoc analysis (Table 1, 
Fig. 4A). The Id2−/− mice serum adiponectin levels were not significantly different from 
WTs when fed with LFD and HFD (Table 1, Supplemental Fig. 2C). The liver total 
cholesterol levels in males showed a similar pattern across experimental groups as serum 
total cholesterol, but not reaching statistical significance (Table 1, Fig. 4B). Surprisingly, 
although the liver TG levels in Id2−/− males fed with LFD were significantly lower than 
WTs, there was striking accumulation of TG in Id2−/− males when fed with HFD compared 
to WTs (Table 1, Fig. 4B). Furthermore, these differences were observed in males only. Oil-
red-O staining of liver sections confirmed this distinct pattern of lipid accumulation in Id2−/
− male mice: a depletion of lipids on LFD but significantly higher levels of lipid on HFD, as 
compared to WTs (Fig. 4C).
Zhou et al. Page 5
Biochem Biophys Res Commun. Author manuscript; available in PMC 2015 August 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Discussion
In this study, we have explored the effects of ID2 deficiency on energy metabolism in mice. 
Loss of ID2 inhibited weight gain in animals exposed to a LFD. This could be attributed, in 
part, to reduced adiposity, as shown in the current study and prior work, as well as impaired 
adipogenesis, and increased energy expenditure from iBAT and skeletal muscle [3,4,9]. 
High fat diet moderately ameliorates the gaining weight capacity of Id2−/− male mice only. 
This sexual dimorphism may be attributed to multiple factors, such as the sex difference in 
the fat deposition and storage, hormones, and metabolism [14,15]. Interestingly, we also 
found that the survival rate of Id2−/− male mice was significantly improved by a HFD. One 
possibility might be amelioration of body weight loss and reduced fat mass, as mice with no 
WAT fat (A-ZIP/F-1 mice) show a high mortality rate [16]. Moreover, no significant decline 
in body weight prior to death was found. It is also plausible that the cause or contribution to 
the sudden occurrence of death was due to heart failure; it has been reported previously that 
Id2−/− mice have an abnormal cardiac morphology and intraventricular conduction [17]. 
Since HDL cholesterol levels are particularly higher in Id2−/− male mice on HFD 
compared to other groups of Id2−/− mice, this may help improve their cardiac function.
In this study, both female and male Id2−/− mice showed increased glucose tolerance, except 
for HFD males. MicroCT analysis revealed sex differences in total fat storage of Id2−/− 
mice under HFD. Moreover, assessment of gonadal WAT mass suggests that there are 
increased visceral fat depots in Id2−/− male mice under HFD, whereas there is less stored in 
visceral fat in females on both diets. Furthermore, serum leptin levels were consistent with 
the appropriate WAT/body mass ratio. Since previous studies show a clear association 
between visceral fat accumulation and insulin sensitivity, increased visceral fat depots in 
Id2−/− males might contribute to a loss of enhanced glucose tolerance [18,19]. In addition, 
hepatic steatosis may also compromise glucose metabolism in the HFD-fed Id2−/− mice. 
Our previous findings also revealed that increased energy expenditure is compensated in 
Id2−/− male mice through increasing food intake and reducing locomotor activity [9]. 
However, an energy-rich diet may undermine this compensation effect in a sex-specific 
manner, which may contribute to fat accumulation, loss of the lean phenotype and loss of 
enhanced glucose tolerance.
Interestingly, despite the lack of a marked change in circulating adiponectin levels, ectopic 
lipid accumulation occurred in the liver of Id2−/− mice in a sex-specific manner. Id2−/− 
male liver showed an opposite effect on TG levels under low and high fat diets. This 
observation could be explained in part by earlier findings that lipoprotein lipase (Lpl) was 
found to be up-regulated in the liver of Id2−/− mice under regular chow diet in a time-
specific manner [3]. Hepatic-specific overexpression of LPL leads results in hepatic 
steatosis [20,21]. Another possibility for the steatosis is the spillover of fat from adipose 
tissue, as the total fat mass is increased in the Id2−/− male mice.
According to our data, we propose the following possible mechanisms to explain the sexual 
dimorphism observed in Id2−/− mice. First, female Id2−/− mice have higher adiponectin 
levels than their male counterparts. Since adiponectin is an important adipokine that 
regulates systemic insulin sensitivity and lipid metabolism [22], female Id2−/− mice 
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maintain glucose tolerance and moderate levels of hepatic lipid contents even on high-fat 
diet. Second, an increase in circulated glucagon in Id2−/− females may also improve lipid 
homeostasis in adipose tissue and liver lipid degradation [23]. In addition, sex-specific 
adipocyte programing [9,14] and differences in hepatic lipid uptake and export might play 
important roles as well. Given that Id2 is implicated in regulating circadian clock output 
[3,9], it is also possible that the Id2−/− mouse phenotypes could be a result of poor intra- 
and inter-organ temporal coordination of metabolic processes, including central nervous 
system control and intestinal lipid absorption [24,25]. These data and other pieces of 
evidence suggest that Id2−/− mice have defects in adipogenesis and lipid metabolism, which 
might include disturbances to rhythmic and non-rhythmic regulation of genes and processes 
necessary for adipocyte differentiation and function, lipid synthesis/uptake, metabolism 
and/or storage [26,27]. In conclusion, our current data and earlier reports suggest that ID2 is 
a potential therapeutic target for treating metabolic disorders. Further, these data reinforce 
the relevance of sex-specific analyses in studying models of metabolic function as they 
pertain to human health and disease.
Supplementary Material
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• High fat diet ameliorates Id2−/− mice phenotype and survival rate sex 
specifically
• High fat diet modulates Id2−/− mice glucose homeostasis in a sex dependent 
manner
• High fat diet modulates lipid metabolic homeostasis of Id2−/− mice sex 
specifically
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Fig. 1. Sex- and diet specific regulation of growth and survival rate in Id2−/− mice
(A) Weekly body weight measurements of WT and Id2−/− male (left) and female (right) 
mice fed with low fat diet (LFD) or high fat diet (HFD) over 17 weeks. (B) Upper: Growth 
rate (fold change) of WT and Id2−/− male (Left: LFD; Right: HFD). Lower: Growth rate 
(fold change) of WT and Id2−/− female (Left: LFD; Right: HFD). Values are mean ± 
S.E.M. RM-ANOVA were performed followed by Tukey’s post-hoc tests, *p<0.05, 
**p<0.01, ***p<0.001. (C) Percentage survival rate of the WT and Id2−/− mice during the 
20 wk experiment.
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Fig. 2. Sex-specific modulation of Id2−/− mice glucose homeostasis under high fat diet
(A) Glucose tolerance tests of WT and Id2−/− male mice (Left: LFD; Right: HFD). (B) 
Glucose tolerance tests of WT and Id2−/− female mice. (Left: LFD; Right: HFD). Values 
are mean ± S.E.M. Two- factor ANOVA were performed followed by Tukey’s post-hoc 
tests, *p<0.05, **p<0.01.
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Fig. 3. Sex-specific modulation of fat storage of Id2−/− mice under high fat diet
(A) MicroCT representative 3D visual display of global fat deposits of WT and Id2−/− male 
mice. (B) MicroCT examination of the ratio of total fat to body volume (left) and of lower 
abdominal fat (LAF) volume to total volume (right) from WT and Id2−/− mice fed with 
LFD or HFD. (C) Ratio of weight of gonadal white adipose tissue to total body mass (left) 
and of weight of iBAT to total body mass (Right) from WT and Id2−/− fed with LFD and 
HFD. Values are mean ± S.E.M. Two factor-ANOVAs were performed followed by 
Tukey’s post-hoc tests, *p<0.05, ***p<0.001.
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Figure 4. High fat diet differentially modulates lipid metabolic homeostasis of Id2−/− male mice
(A) Serum total cholesterol (left), LDL cholesterol (middle) and leptin (right) of WT and 
Id2−/− under LFD or HFD. (B) Liver total cholesterol (left) and triglyceride (right) of WT 
and Id2−/− under LFD or HFD. (C) Representative Oil-red-O and Hematoxylin-Eosin 
stained liver section from WT and Id2−/− male mice liver fed with LFD or HFD. Scale bar, 
100 μm. Oil-red-O quantification values, mean ± S.E.M., on the right. Two factor-ANOVAs 
were performed followed by Tukey’s post-hoc tests, *p<0.05, **p<0.01, ***p<0.001.
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